Zai Lab (ZLAB) News
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.03-0.89 (-4.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ZLAB news summary
We found 3 recent headlines mentioning Zai Lab (ZLAB): 0 in the past week and 1 in the past 30 days, most often from Business Wire, Nasdaq. For price context, ZLAB is down 4.06% at $21.03. The most recent story, "Zai Lab Announces Third Quarter 2026 Financial Results and Recent Corporate Updates", was published by Business Wire on Nov 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Zai Lab headlines
- Zai Lab Announces Third Quarter 2026 Financial Results and Recent Corporate UpdatesSHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma, today announced financial results for the third quarter of 2026,…Business Wire
- Zai Lab Limited Announces $250 Million Private PlacementZai Lab Limited entered into a securities purchase agreement on October 22, 2026, with certain accredited investors to sell 11,340,000 American depositary shares (ADSs) in a private placement…Nasdaq
- Zai Lab to Announce Third Quarter 2026 Financial Results and Recent Corporate Updates on November 5, 2026SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its third quarter 2026 financial results and provide recent corporate…Business Wire